Moteur de recherche d’entreprises européennes
Financement de l’UE (3 925 220 €) : Formation au réseau d’adhésine virale et bactérienne Hor 10/10/2017 Programme de recherche et d'innovation de l'UE « Horizon »
Vue d’ensemble
Texte
Formation au réseau d’adhésine virale et bactérienne
ViBrANT (VIral and BacteRial Adhesin Network Training) brings together an interdisciplinary team of world-leading European infection researchers, focused on a cutting-edge translational research project to understand host-pathogen adhesion and to develop novel, highly-specific nanoscale diagnostics to improve patient care. Host-pathogen interactions are the basis for infectious diseases, but the research methodologies needed to unravel these interactions and translate them into viable diagnostic tools are complex and change rapidly. ViBrANT will deliver high-impact fundamental and translational science and in so doing will educate 15 ESRs. We have the demonstrated track-record and infrastructure to train ESRs in highly innovative methodologies, including structural biology, proteomics, genetics, comparative genomics, lab-on-a-chip technology and the development of state of the art diagnostics in the field of infectious diseases. ViBrANT will investigate the poorly understood structure-function relationships between pathogen adhesins and hosts in an integrative manner. The ESRs in the project will have extensive intersectoral mobility across 7 EU/EEA countries, accessing the best complementary skills in each of the hosting institutions. ViBrANT comprises 8 leading universities, 1 public research institution and 6 companies (from SME to multinational). The project will impact adhesion biology in general; the detection of multi-antibiotic resistant human pathogens will have priority. The ESRs will acquire the necessary skills to translate fundamental research into technologies that will have a strong positive effect on the care of patients with infectious diseases. ViBrANT science will be high-impact and deliver 15 highly-trained innovative researchers and a long-lasting inter-sectoral collaborative network. Together, we will continue to develop fundamental research and translate it for the socio-economic benefit of Europe.
| Biomode 2 SA | ? |
| Biomerieux SA | 525 751 € |
| Centitvc - Centro de Nanotecnologiae Materiais Tecnicos Funcionais Einteligentes | 238 356 € |
| Eberhard Karls Universitaet Tuebingen | 249 216 € |
| Helsingin Yliopisto | 269 145 € |
| Institut Pasteur | 262 876 € |
| Johann Wolfgang Goethe-Universitaet Frankfurt AM Main | 498 433 € |
| Lunds Universitet | 263 659 € |
| Universidade do Minho | 238 356 € |
| Universitetet I Oslo | 286 275 € |
| University of Hull | 273 288 € |
| University of Leeds | 819 864 € |
https://cordis.europa.eu/project/id/765042
Cette annonce se réfère à une date antérieure et ne reflète pas nécessairement l’état actuel. L’état actuel est présenté à la page suivante : Biomode 2 SA, Braga, Portugal.
